查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1766294

神經內視鏡市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Neuroendoscopy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年，全球神經內視鏡市場規模達1.688億美元，預計到2034年將以5.7%的複合年成長率成長，達到2.908億美元。這一成長主要源於腦腫瘤發生率的上升以及對微創手術的需求不斷成長。神經內視鏡設備在腦腫瘤（包括膠質瘤和腦下垂體腺瘤）的診斷和治療中發揮著至關重要的作用。隨著全球神經系統疾病發生率的持續上升，對先進專用神經外科器械的需求也隨之成長。這些工具在實現更準確的診斷、提高手術精準度和縮短患者復原時間方面發揮關鍵作用。

神經內視鏡市場 - IMG1

隨著醫療保健提供者越來越重視能夠最大程度減少創傷並改善患者預後的技術，向微創手術的轉變正在進一步推動微創手術的普及。導航系統、機器人技術和微型器械的技術進步顯著提高了手術能力，使神經外科醫生即使在大腦和脊椎等精細複雜的部位也能進行更精準的手術。隨著全球醫療保健系統加強對外科基礎設施現代化的投資，神經外科器械在應對日益加重的神經系統疾病負擔方面發揮更關鍵的作用。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 1.688億美元
預測值 2.908億美元
複合年成長率 5.7%

市場分為硬性神經內視鏡和軟性神經內視鏡，其中硬性型號收入最高。硬性神經內視鏡市場在2024年創造了1.131億美元的收入，為複雜的手術提供了卓越的功能。這些設備在腫瘤切除和腦室造口術等手術中發揮重要作用，能夠清楚觀察顱內和脊髓結構。其設計提高了手術的精準度，使其成為神經外科醫生的重要工具。

根據可用性，神經內視鏡進一步分為可重複使用型和一次性型。可重複使用型神經內視鏡市場在2024年創造了1.465億美元的收入。這些儀器對醫療保健提供者，尤其是在手術量大的機構中，具有經濟效益。可重複使用的設備還能支援醫療保健產業的永續發展，因為它們可以減少浪費並符合環境目標。其耐用性和長期成本節約使其在世界各地的醫療機構中越來越受歡迎。

2024年，美國神經內視鏡市場規模達5,990萬美元，2025年至2034年期間的複合年成長率為4.9%。神經系統疾病發生率的上升以及對高效微創治療的需求推動了這一成長。美國市場將更多地採用先進技術，例如整合式高清成像系統的機器人神經內視鏡。這一轉變預計將改善手術效果並縮短患者康復時間，從而推動對神經內視鏡手術的需求。

活躍於全球神經內視鏡市場的知名公司包括 Machida、ADVANCED BIOLOGICS、B. Braun、CLARUS MEDICAL、Advin Health Care、SCHINDLER ENDOSKOPIE TECHNOLOGIE、KARL STORZ、重慶西山科技、joimax、adeormannCAL 和 Ackercker MEDICAL 和 Ackercker。神經內視鏡市場公司採取的關鍵策略包括投資研發以提高設備精度和小型化，透過先進的成像和導航整合擴展產品組合，以及與醫院和學術機構建立策略合作夥伴關係以加速臨床應用。領先的參與者還專注於透過加強區域分銷網路和獲得監管部門的批准來進入尚未開發的市場。持續創新旨在減少手術侵入性和改善患者復原結果，對於保持競爭力和擴大全球影響力仍然至關重要。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 腦瘤病例不斷增加
      • 微創外科手術需求激增
      • 神經外科的技術進步
      • 老年人口不斷增加
    • 產業陷阱與挑戰
      • 設備和手術費用高昂
      • 缺乏熟練的神經外科醫生
    • 市場機會
      • 產品創新和客製化
      • 醫療旅遊和醫療保健投資不斷成長
  • 成長潛力分析
  • 監管格局
    • 美國
    • 歐洲
  • 技術和創新格局
  • 報銷場景
  • 差距分析
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板
  • 關鍵進展
    • 併購
    • 夥伴關係和合作
    • 新產品發布
    • 擴張計劃

第5章：市場估計與預測：按產品，2021 - 2034 年

  • 主要趨勢
  • 硬質神經內視鏡
    • 硬質纖維鏡
    • 硬式視訊內視鏡
  • 軟性神經內視鏡

第6章：市場估計與預測：按應用，2021 - 2034 年

  • 主要趨勢
  • 經鼻神經內視鏡檢查
  • 腦室內神經內視鏡檢查
  • 經顱神經內視鏡檢查

第7章：市場估計與預測：按可用性，2021 - 2034 年

  • 主要趨勢
  • 可重複使用的神經內視鏡
  • 免洗神經內視鏡

第 8 章：市場估計與預測：按患者，2021 年至 2034 年

  • 主要趨勢
  • 成人
  • 兒科

第9章：市場估計與預測：依最終用途，2021 - 2034 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他最終用途

第10章：市場估計與預測：按地區，2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：公司簡介

  • Ackermann
  • adeor MEDICAL
  • ADVANCED BIOLOGICS
  • Advin Health care
  • B. Braun
  • Chongqing Xishan Science & Technology
  • CLARUS MEDICAL
  • joimax
  • KARL STORZ
  • Machida
  • SCHINDLER ENDOSKOPIE TECHNOLOGIE
簡介目錄
Product Code: 4039

The Global Neuroendoscopy Market was valued at USD 168.8 million in 2024 and is estimated to grow at a CAGR of 5.7% to reach USD 290.8 million by 2034. The growth is largely driven by the increasing prevalence of brain tumors and the rising demand for minimally invasive procedures. Neuroendoscopic devices play a crucial role in the diagnosis and treatment of brain tumors, including gliomas and pituitary adenomas. As the global incidence of neurological disorders continues to rise, so does the demand for advanced and specialized neurosurgical instruments. These tools play a critical role in enabling more accurate diagnostics, improved surgical precision, and reduced patient recovery times.

Neuroendoscopy Market - IMG1

The shift toward minimally invasive procedures is further driving adoption, as healthcare providers increasingly prioritize techniques that minimize trauma and enhance patient outcomes. Technological advancements in navigation systems, robotics, and micro-instruments have significantly improved surgical capabilities, allowing neurosurgeons to operate with higher precision even in delicate and complex areas of the brain and spine. As healthcare systems worldwide invest more in modernizing their surgical infrastructure, the role of neurosurgical instruments becomes even more central in addressing the growing burden of neurological diseases.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$168.8 Million
Forecast Value$290.8 Million
CAGR5.7%

The market is divided into rigid and flexible neuroendoscopes, with rigid models generating the highest revenue. The rigid neuroendoscope segment generated USD 113.1 million in 2024, offering superior functionality for complex procedures. These devices are instrumental in procedures like tumor resections and ventriculostomies, offering excellent visibility of intracranial and spinal structures. Their design allows for better precision during surgeries, making them a vital tool for neurosurgeons.

Neuroendoscopes are further categorized based on usability into reusable and disposable types. The reusable neuroendoscopes segment generated USD 146.5 million in 2024. These instruments are economically beneficial for healthcare providers, especially in facilities with a high volume of procedures. Reusable devices also support sustainability efforts in the healthcare sector, as they reduce waste and align with environmental goals. Their durability and long-term cost savings make them increasingly popular in medical facilities worldwide.

United States Neuroendoscopy Market generated USD 59.9 million in 2024 with a CAGR of 4.9% between 2025-2034. This growth is spurred by the increasing incidence of neurological disorders and the need for efficient, minimally invasive treatments. The U.S. market will see enhanced adoption of advanced technologies, such as robotic neuroendoscopes, which integrate high-definition imaging systems. This shift is expected to improve surgical outcomes and patient recovery times, driving demand for neuroendoscopic procedures.

Prominent companies active in the Global Neuroendoscopy Market include Machida, ADVANCED BIOLOGICS, B. Braun, CLARUS MEDICAL, Advin Health Care, SCHINDLER ENDOSKOPIE TECHNOLOGIE, KARL STORZ, Chongqing Xishan Science & Technology, joimax, adeor MEDICAL, and Ackermann. Key strategies adopted by companies in the neuroendoscopy market include investing in research and development to enhance device precision and miniaturization, expanding product portfolios with advanced imaging and navigation integration, and forming strategic partnerships with hospitals and academic institutions to accelerate clinical adoption. Leading players are also focused on entering untapped markets by strengthening regional distribution networks and securing regulatory approvals. Continuous innovation aimed at reducing surgical invasiveness and improving patient recovery outcomes remains central to maintaining competitiveness and expanding global presence.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Application trends
    • 2.2.4 Usability trends
    • 2.2.5 Patient trends
    • 2.2.6 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of brain tumor cases
      • 3.2.1.2 Surging demand for minimally invasive surgical procedures
      • 3.2.1.3 Technological advancements in neurosurgery
      • 3.2.1.4 Growing elderly population
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with devices and surgeries
      • 3.2.2.2 Lack of skilled neurosurgeons
    • 3.2.3 Market opportunities
      • 3.2.3.1 Product innovations and customization
      • 3.2.3.2 Rising medical tourism and healthcare investments
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technology and innovation landscape
  • 3.6 Reimbursement scenario
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends
  • 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 By Region
      • 4.3.1.1 North America
      • 4.3.1.2 Europe
      • 4.3.1.3 Asia Pacific
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard
  • 4.7 Key developments
    • 4.7.1 Mergers and acquisitions
    • 4.7.2 Partnerships and collaborations
    • 4.7.3 New product launches
    • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Rigid neuroendoscopes
    • 5.2.1 Rigid fiberscopes
    • 5.2.2 Rigid videoscopes
  • 5.3 Flexible neuroendoscopes

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Transnasal neuroendoscopy
  • 6.3 Intraventricular neuroendoscopy
  • 6.4 Transcranial neuroendoscopy

Chapter 7 Market Estimates and Forecast, By Usability, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Reusable neuroendoscopes
  • 7.3 Disposable neuroendoscopes

Chapter 8 Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Adult
  • 8.3 Pediatric

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Ambulatory surgical centers
  • 9.4 Diagnostic centers
  • 9.5 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 Ackermann
  • 11.2 adeor MEDICAL
  • 11.3 ADVANCED BIOLOGICS
  • 11.4 Advin Health care
  • 11.5 B. Braun
  • 11.6 Chongqing Xishan Science & Technology
  • 11.7 CLARUS MEDICAL
  • 11.8 joimax
  • 11.9 KARL STORZ
  • 11.10 Machida
  • 11.11 SCHINDLER ENDOSKOPIE TECHNOLOGIE